Acquisition of Manufacturing and Marketing Approval for SARS-CoV-2 Antigen Rapid Test and Release on 14th February
TOKYO, JAPAN - Medical & Biological Laboratories Co., Ltd. (President: Kimimasa Yamada), a JSR Life Sciences company, successfully acquired manufacturing and marketing approval for a rapid antigen test for SARS-CoV-2, “GLINE-2019-nCoV Ag kit” (Product code: YH-G86256). The kit is scheduled to be released on February 14th in Japan.
Contact details
-
Download vCard
- Missy Bindseil
-
JSR Life Sciences Company Inquiries
Director, Marketing & Communications - mbindseil@jsr-nahq.com
Related topics
Related news
Crown Bioscience and MBL Enter Joint Venture to Provide Advanced Preclinical Services for Japanes...
Crown Bioscience and MBL announce the formation of a joint venture, to further expand the provision of Crown Bioscience’s preclinical services to Japanese customers.
MBL Launches Five-test Kit for Rapid SARS-CoV-2 Antigen Detection
This product is a five-test kit version of GLINE-2019-nCoV Ag Kit (Code No. YH-G86256) which was released on February 14th as a one test kit
Launch of a New Kit for the Detection of Anti-Integrin αvβ6 Antibodies for Understanding Patholog...
Anti-integrin αvβ6 antibodies are detected in about 90% of UC patients, and the results of basic research suggest that these autoantibodies themselves may be causing the disease
MBL Donated 20,000 SARS-CoV-2 Antigen Test Kits to Ina City, Nagano Prefecture in Japan
MBL donated 20,000 their SARS-CoV-2 antigen test kits "GLINE-2019-nCoV Ag kit" to Ina City, Nagano Prefecture, where their research and production facilities are located